The article reports on the immunology and diagnosis of lupus nephritis (LN). It states that traditionally, serum levels of anti-dsDNA antibodies and hypocomplementemia are used to identify patients with high disease activity and at risk for developing LN. It says that biomarkers reflecting systemic lupus erythematosus (SLE) disease activity and providing specificity for renal lupus are likely to be found in the urine.